Thursday, December 15, 2022 8:41:51 AM
A problem for Amarin has been that Vascepa is TOO EFFECTIVE
cash [not] paid out by governments for Vascepa would have to be spent in even larger amounts for hospital bills{not to mention those countrymen, who would die from avoidable CVD)
